We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Assurant Eyes Long-Term Growth; Low Interest Rates a Drag
Read MoreHide Full Article
On Sep 5, 2016, we issued an updated research report on Assurant, Inc. (AIZ - Free Report) .
Assurant remains committed to boosting long-term growth and in keeping with the plan has been restructuring its business. To this end, the company has divested its Employee Benefits business and intends to exit the health insurance market in 2016. The insurer has also been focusing on Specialty Property and Casualty and Lifestyle Protection businesses.
Notably, the company received dividends worth $604 million following the sale of Employee Benefits. Also, it anticipates more dividend receipts in the later part of 2016 and in 2017 as it releases its capital. This should further support the business.
Moreover, Assurant remains focused on evolving the lender-placed platform at Specialty Property to further enhance its market-leading position. The insurer expects the capital generated from Solutions and Specialty Property to offer enough flexibility for effective capital deployment to further boost its operations. Also, management intends to return $1.5 billion to shareholders by the end of 2017. This makes it an attractive pick for yield seeking investors.
However, intense competition in the domestic as well as international markets and low interest rates remain headwinds.
In addition, as Assurant Health is expected to fully exit the health insurance market in 2016, the company is likely to incur $13–$23 million pre-tax of extra exit-related charges and overhead expenses, which might hurt the bottom line.
The Zacks Consensus Estimate has also witnessed downward revisions over the last 60 days as most of the estimates trended south. Nonetheless, banking on the operational strength, management projects at least 15% annual increase in operating earnings per share and 15% growth in return on equity by 2020.
Zacks Rank and Stocks to Consider
Currently, Assurant carries a Zacks Rank #3 (Hold). Some better-ranked stocks from the same space are ageas SA/NV (AGESY - Free Report) , CNO Financial Group, Inc. (CNO - Free Report) and James River Group Holdings, Ltd. (JRVR - Free Report) . Each of the stocks holds a Zacks Rank #2 (Buy).
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Assurant Eyes Long-Term Growth; Low Interest Rates a Drag
On Sep 5, 2016, we issued an updated research report on Assurant, Inc. (AIZ - Free Report) .
Assurant remains committed to boosting long-term growth and in keeping with the plan has been restructuring its business. To this end, the company has divested its Employee Benefits business and intends to exit the health insurance market in 2016. The insurer has also been focusing on Specialty Property and Casualty and Lifestyle Protection businesses.
Notably, the company received dividends worth $604 million following the sale of Employee Benefits. Also, it anticipates more dividend receipts in the later part of 2016 and in 2017 as it releases its capital. This should further support the business.
Moreover, Assurant remains focused on evolving the lender-placed platform at Specialty Property to further enhance its market-leading position. The insurer expects the capital generated from Solutions and Specialty Property to offer enough flexibility for effective capital deployment to further boost its operations. Also, management intends to return $1.5 billion to shareholders by the end of 2017. This makes it an attractive pick for yield seeking investors.
However, intense competition in the domestic as well as international markets and low interest rates remain headwinds.
In addition, as Assurant Health is expected to fully exit the health insurance market in 2016, the company is likely to incur $13–$23 million pre-tax of extra exit-related charges and overhead expenses, which might hurt the bottom line.
The Zacks Consensus Estimate has also witnessed downward revisions over the last 60 days as most of the estimates trended south. Nonetheless, banking on the operational strength, management projects at least 15% annual increase in operating earnings per share and 15% growth in return on equity by 2020.
Zacks Rank and Stocks to Consider
Currently, Assurant carries a Zacks Rank #3 (Hold). Some better-ranked stocks from the same space are ageas SA/NV (AGESY - Free Report) , CNO Financial Group, Inc. (CNO - Free Report) and James River Group Holdings, Ltd. (JRVR - Free Report) . Each of the stocks holds a Zacks Rank #2 (Buy).
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>